Mankind Pharma management on FY24 growth outlook, new launches and balance sheet

Shares of Mankind Pharma made a remarkable debut on the stock exchanges on Tuesday, listing with a premium of over 20 per cent against the issue price of Rs 1,080. The stock began the trade at Rs 1,300, up 20.37 per cent on the BSE. It further zoomed 24.53 per cent to Rs 1,366. What is the growth outlook for the company for FY24? Ramesh Juneja, the Chairman, and Rajeev Juneja, Vice-Chairman and Managing Director of the co speak about the way forward, new launches and balance sheet.